Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A concise guide to retirement funds with the lowest fees, detailing how fees affect compounding and overall retirement outcomes.
27,102 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
A sharp 27% drop for AppLovin stock has investors weighing risk and reward. This guide breaks down the business, the ...
A lump-sum windfall sitting in cash while markets churn often misses the gains of staying invested. Experts say a dis...
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
The AI investment surge captured headlines and portfolios alike, but the rally isn’t smooth sailing. This article exp...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
ICE appoints a former GEO Group executive as acting director this week, signaling a shift in immigration enforcement ...
Investors who have stacked some massive capital gains are weighing tax-efficient exit strategies as markets reach fre...
Housing advocates warn that proposed HUD funding reductions threaten affordability and housing supply as Congress con...
Oil prices surged after ships halted near Hormuz amid Iranian warnings, signaling a potential energy shock for househ...
Trump argues against rate hikes amid a stubborn inflation backdrop, while Kevin Warsh appears set to influence a hawk...